Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Laminin 332 is essential for normal skin cell behavior and structure.

JAK inhibitors might help treat Lichen Planopilaris, but more research is needed.

A new treatment using unactivated platelet leukocyte autoplasma cured 80% of non-scarring alopecia patients.

Lichen planopilaris and frontal fibrosing alopecia are likely distinct diseases with different tissue involvement.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Adipose tissue-derived exosomes may help treat lichen planopilaris and preserve hair.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Sphingosine 1-phosphate affects inflammation and gene expression in different aorta cells.

Injectable biostimulators can improve skin by boosting collagen and fat cell activity, but more research is needed to confirm their safety and effectiveness.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

L-(+)-Tartaric Acid may help increase certain hair growth genes without harming cells.

Low-level laser therapy reduces orthodontic relapse in rats, but fulvic acids do not.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

PRP and LLLT can improve hair growth in AGA, but more research needed.

GLABRA2 gene controls root-hair growth by regulating phospholipid signaling.

Lhx2 is essential for effective Sonic Hedgehog signaling in early retinal development.

Cooling the skin before injections reduces pain for patients with hair loss.

Neurotrophins regulate nerve growth by balancing promotion and suppression.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

GLP-1RA therapy may increase the risk of hair loss.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Lichen planopilaris may have a genetic link.